AIM: To investigate the loss of heterozygosity (LOH) and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. METHODS: Thirty cases of normal gastric mucosa, advanced and early stage gastric cancer, intestinal metaplasia, atrophic gastritis, and atypical hyperplasia were analyzed for PTEN LOH and mutations within the entire coding region of PTEN gene by PCR-SSCP denaturing PAGE gel electrophoresis, and PTEN mutation was detected by PCR-SSCP sequencing followed by silver staining. RESULTS: LOH rate found in respectively atrophic gastritis was 10% (3/30), intestinal metaplasia 10% (3/30), atypical hyperplasia 13.3% (4/30), early stage gastric cancer 20% (6/30), and advanced stage gastric cancer 33.3% (9/30), None of the precancerous lesions and early stage gastric cancer showed PTEN mutations, but 10% (3/30) of the advanced stage gastric cancers, which were all positive for LOH, showed PTEN mutation. CONCLUSION: LOH of PTEN gene appears in precancerous lesions, and PTEN mutations are restricted to advanced gastric cancer, LOH and mutation of PTEN gene are closely related to the infiltration and metastasis of gastric cancer.
AIM: To investigate the loss of heterozygosity (LOH) and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. METHODS: Thirty cases of normal gastric mucosa, advanced and early stage gastric cancer, intestinal metaplasia, atrophic gastritis, and atypical hyperplasia were analyzed for PTEN LOH and mutations within the entire coding region of PTEN gene by PCR-SSCP denaturing PAGE gel electrophoresis, and PTEN mutation was detected by PCR-SSCP sequencing followed by silver staining. RESULTS: LOH rate found in respectively atrophic gastritis was 10% (3/30), intestinal metaplasia 10% (3/30), atypical hyperplasia 13.3% (4/30), early stage gastric cancer 20% (6/30), and advanced stage gastric cancer 33.3% (9/30), None of the precancerous lesions and early stage gastric cancer showed PTEN mutations, but 10% (3/30) of the advanced stage gastric cancers, which were all positive for LOH, showed PTEN mutation. CONCLUSION: LOH of PTEN gene appears in precancerous lesions, and PTEN mutations are restricted to advanced gastric cancer, LOH and mutation of PTEN gene are closely related to the infiltration and metastasis of gastric cancer.
Authors: Ke Ning; Lin Pei; Mingxia Liao; Baosong Liu; Yunzhou Zhang; Wen Jiang; John G Mielke; Lei Li; Yonghong Chen; Youssef H El-Hayek; Michael G Fehlings; Xia Zhang; Fang Liu; James Eubanks; Qi Wan Journal: J Neurosci Date: 2004-04-21 Impact factor: 6.167
Authors: S C Huang; C R Chen; J E Lavine; S F Taylor; R O Newbury; T T Pham; L Ricciardiello; J M Carethers Journal: Cancer Res Date: 2000-12-15 Impact factor: 12.701
Authors: Elaine A Orchiston; Deborah Bennett; Nick R Leslie; Rosemary G Clarke; Lucinda Winward; C Peter Downes; Stephen T Safrany Journal: J Biol Chem Date: 2003-10-15 Impact factor: 5.157
Authors: Ana Vega; Josema Torres; María Torres; José Cameselle-Teijeiro; Manuel Macia; Angel Carracedo; Rafael Pulido Journal: J Invest Dermatol Date: 2003-12 Impact factor: 8.551
Authors: Sunghoon Kim; Claire Domon-Dell; Qingding Wang; Dai H Chung; Antonio Di Cristofano; Pier Paolo Pandolfi; Jean-Noel Freund; B Mark Evers Journal: Gastroenterology Date: 2002-10 Impact factor: 22.682
Authors: Gordon B Mills; Elise Kohn; Yiling Lu; Astrid Eder; Xianjun Fang; Hongwei Wang; Robert C Bast; Joe Gray; Robert Jaffe; Gabriel Hortobagyi Journal: Semin Oncol Date: 2003-10 Impact factor: 4.929
Authors: Adam M Gustafson; Raffaella Soldi; Christina Anderlind; Mary Beth Scholand; Jun Qian; Xiaohui Zhang; Kendal Cooper; Darren Walker; Annette McWilliams; Gang Liu; Eva Szabo; Jerome Brody; Pierre P Massion; Marc E Lenburg; Stephen Lam; Andrea H Bild; Avrum Spira Journal: Sci Transl Med Date: 2010-04-07 Impact factor: 17.956